Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00610402 · ClinicalTrials.gov registry record
Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 57
- Enrollment target
NCT00610402: Completed study, sponsored by University of California, Irvine.
NCT00610402 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00610402 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
Sturge-Weber Syndrome (SWS) is a neurological disorder characterized at birth by seizures and a large port-wine stain birthmark on the forehead and upper eyelid of one side of the face. SWS is also accompanied by an increased pressure within the eye (glaucoma) which can develop very early in life. Glaucoma represents a group of ocular disorders that are characterized by the loss of retinal ganglion cells and their axons, damage to the optic nerve, and gradual loss of visual field. Recently, several studies provided evidence that there is a potential role of the immune system in the pathogenesis of glaucoma. These findings suggest that there might be changes in systemic humoral immunity possibly underlying the optic neuropathy in at least some glaucoma patients.
Interventions
- OTHER blood sample tear drop sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-06 |
What the finished NCT00610402 record still lists
NCT00610402 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which blood sample tear drop sample is the first listed.
NCT00610402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00610402 about?
NCT00610402 is a clinical study titled "Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)". Sturge-Weber Syndrome (SWS) is a neurological disorder characterized at birth by seizures and a large port-wine stain birthmark on the forehead and upper eyelid of one side of the face. SWS is also accompanied by an increased pressure within the eye (glaucoma) which can develop very early in life. ...
What is the current status of trial NCT00610402?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2007-07. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00610402?
The interventions under investigation include: blood sample tear drop sample (OTHER).
Who is sponsoring clinical trial NCT00610402?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia